Business · 03/08/2005Updated: 10/17/2026 · 1 min read
FDA Extends Authorization for Anthrax Vaccine for High-Risk Individuals
The FDA is extending the Emergency Use Authorization for Anthrax Vaccine Adsorbed for individuals aged 18-65 deemed at heightened risk of exposure due to potential anthrax attacks, following a request from the Department of Defense.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →